Pub Date : 2025-10-13eCollection Date: 2025-01-01DOI: 10.3389/fepid.2025.1681088
Maryam Bolouri, Nazia S Sayed, Maureen R Benjamins, Nicholas R Munoz, Tyler Halterman, Abigail Silva
Background: Colorectal cancer (CRC) is a leading cause of cancer deaths in the United States. While national CRC mortality rates have improved over time, this rate differs between non-Hispanic (nH) Black and nH White populations and by geography.
Methods: The 30 most populous cities in the US were analyzed using national vital statistics data. Numerators were obtained from death certificates of residents of these cities with CRC as the underlying cause of death. US Census data provided population-based denominators. We calculated Black:White rate ratios (RRs) and corresponding confidence intervals for the most recent time period studied (2017-2019) to assess racial inequities. We calculated average annual percent changes to evaluate CRC mortality trends from 2009-2019.
Results: CRC mortality rates statistically significantly decreased nationally and in 25 of the 30 cities. In most cities, nH Black populations experienced a greater decrease in CRC mortality over time than nH White populations. However, in 20 cities, the Black:White CRC mortality rate ratio was greater than 1 (ranging from 1.28 in New York to 2.68 in Washington, D.C.; p < 0.05), indicating persistent racial inequities. Between 2009 and 2019, six cities saw statistically significant decreases in racial inequities, two cities saw increases, and the remaining cities demonstrated persistent disparities.
Conclusions: Despite improvements in CRC mortality, Black:White disparities persist. Structural racism may contribute to these disparities through differential access to care and risk factor exposure. Identifying geographic differences in Black:White CRC mortality may serve as a catalyst for local governments to implement place-based initiatives that reduce screening barriers and contribute to health equity.
{"title":"Pre-pandemic patterns in colorectal cancer mortality and Black-White inequities across the 30 most populous US cities.","authors":"Maryam Bolouri, Nazia S Sayed, Maureen R Benjamins, Nicholas R Munoz, Tyler Halterman, Abigail Silva","doi":"10.3389/fepid.2025.1681088","DOIUrl":"10.3389/fepid.2025.1681088","url":null,"abstract":"<p><strong>Background: </strong>Colorectal cancer (CRC) is a leading cause of cancer deaths in the United States. While national CRC mortality rates have improved over time, this rate differs between non-Hispanic (nH) Black and nH White populations and by geography.</p><p><strong>Methods: </strong>The 30 most populous cities in the US were analyzed using national vital statistics data. Numerators were obtained from death certificates of residents of these cities with CRC as the underlying cause of death. US Census data provided population-based denominators. We calculated Black:White rate ratios (RRs) and corresponding confidence intervals for the most recent time period studied (2017-2019) to assess racial inequities. We calculated average annual percent changes to evaluate CRC mortality trends from 2009-2019.</p><p><strong>Results: </strong>CRC mortality rates statistically significantly decreased nationally and in 25 of the 30 cities. In most cities, nH Black populations experienced a greater decrease in CRC mortality over time than nH White populations. However, in 20 cities, the Black:White CRC mortality rate ratio was greater than 1 (ranging from 1.28 in New York to 2.68 in Washington, D.C.; <i>p</i> < 0.05), indicating persistent racial inequities. Between 2009 and 2019, six cities saw statistically significant decreases in racial inequities, two cities saw increases, and the remaining cities demonstrated persistent disparities.</p><p><strong>Conclusions: </strong>Despite improvements in CRC mortality, Black:White disparities persist. Structural racism may contribute to these disparities through differential access to care and risk factor exposure. Identifying geographic differences in Black:White CRC mortality may serve as a catalyst for local governments to implement place-based initiatives that reduce screening barriers and contribute to health equity.</p>","PeriodicalId":73083,"journal":{"name":"Frontiers in epidemiology","volume":"5 ","pages":"1681088"},"PeriodicalIF":0.0,"publicationDate":"2025-10-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12554653/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145395737","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-10-07eCollection Date: 2025-01-01DOI: 10.3389/fepid.2025.1659856
Tauqeer Ali, Dedra Buchwald, Dean Shibata, Mary J Roman, Steven Verney, Barbara V Howard, Jason Umans, Shelley Cole, Cynthia West, Ying Zhang, Jessica Reese, Dorothy A Rhoades, Marcia O'Leary, W T Longstreth, Amanda Fretts, Astrid Suchy-Dicey
Background and objective: American Indian populations face disproportionately high rates of atherosclerotic cardiovascular disease (CVD), yet the potential consequences of mid-life carotid atherosclerosis on brain health and cognition later in life remain poorly understood. This study addresses a critical knowledge gap by evaluating whether subclinical carotid atherosclerosis in midlife is associated with later-life structural brain abnormalities and cognitive performance in a large cohort of American Indian adults from the Strong Heart Study. This is the first investigation to explore these associations in this underserved and understudied population, using longitudinal data with vascular, neuroimaging, and cognitive measures.
Methods: A total of 783 participants (mean age 59.9 years) underwent carotid ultrasonography between 1998 and 1999 to assess intima-media thickness and plaque. Between 2010 and 2013, participants received brain magnetic resonance imaging to assess infarcts, hemorrhages, white matter lesions, and brain atrophy. Cognitive function was also evaluated during this period. Multivariable regression models adjusted for sociodemographic, behavioral, and clinical CVD risk factors were used to assess associations.
Results: Greater intima-media thickness was associated with more severe sulcal widening, and presence and extent of plaque were associated with poorer verbal fluency; both findings remained significant after adjustment for sociodemographic, behavioral, and clinical risk factors. No significant associations were observed between carotid measures and the presence of infarcts, hemorrhages, or white matter lesions.
Conclusion: These findings suggest that subclinical carotid atherosclerosis in midlife may contribute to later-life brain atrophy and cognitive vulnerability, particularly in verbal fluency, among American Indians.
{"title":"Carotid artery atherosclerosis, MRI-defined structural brain abnormalities, and cognitive performance in elderly American Indians: The Strong Heart Study.","authors":"Tauqeer Ali, Dedra Buchwald, Dean Shibata, Mary J Roman, Steven Verney, Barbara V Howard, Jason Umans, Shelley Cole, Cynthia West, Ying Zhang, Jessica Reese, Dorothy A Rhoades, Marcia O'Leary, W T Longstreth, Amanda Fretts, Astrid Suchy-Dicey","doi":"10.3389/fepid.2025.1659856","DOIUrl":"10.3389/fepid.2025.1659856","url":null,"abstract":"<p><strong>Background and objective: </strong>American Indian populations face disproportionately high rates of atherosclerotic cardiovascular disease (CVD), yet the potential consequences of mid-life carotid atherosclerosis on brain health and cognition later in life remain poorly understood. This study addresses a critical knowledge gap by evaluating whether subclinical carotid atherosclerosis in midlife is associated with later-life structural brain abnormalities and cognitive performance in a large cohort of American Indian adults from the Strong Heart Study. This is the first investigation to explore these associations in this underserved and understudied population, using longitudinal data with vascular, neuroimaging, and cognitive measures.</p><p><strong>Methods: </strong>A total of 783 participants (mean age 59.9 years) underwent carotid ultrasonography between 1998 and 1999 to assess intima-media thickness and plaque. Between 2010 and 2013, participants received brain magnetic resonance imaging to assess infarcts, hemorrhages, white matter lesions, and brain atrophy. Cognitive function was also evaluated during this period. Multivariable regression models adjusted for sociodemographic, behavioral, and clinical CVD risk factors were used to assess associations.</p><p><strong>Results: </strong>Greater intima-media thickness was associated with more severe sulcal widening, and presence and extent of plaque were associated with poorer verbal fluency; both findings remained significant after adjustment for sociodemographic, behavioral, and clinical risk factors. No significant associations were observed between carotid measures and the presence of infarcts, hemorrhages, or white matter lesions.</p><p><strong>Conclusion: </strong>These findings suggest that subclinical carotid atherosclerosis in midlife may contribute to later-life brain atrophy and cognitive vulnerability, particularly in verbal fluency, among American Indians.</p>","PeriodicalId":73083,"journal":{"name":"Frontiers in epidemiology","volume":"5 ","pages":"1659856"},"PeriodicalIF":0.0,"publicationDate":"2025-10-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12537784/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145350439","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-09-30eCollection Date: 2025-01-01DOI: 10.3389/fepid.2025.1661167
Anna Åkesson, Liana Xhakollari, Agnė Laučytė-Cibulskiene, Anders Grubb, Anders Larsson, Amra Jujic, Martin Magnusson, Anders Christensson, Jonas Björk
Purpose: Glomerular filtration rate (GFR) is used for evaluating kidney function. Creatinine and cystatin C levels are the two endogenous substances used to estimate GFR (eGFRCR and eGFRCYS). The agreement between these two is reflected by the eGFRCYS/eGFRCR ratio. An eGFRCYS/eGFRCR ratio <0.70 has been strongly associated with mortality and morbidity. An explanation is a selective decrease in the filtration of substances of different masses, and this condition is referred to as "Shrunken pore syndrome" (SPS). We aim to investigate the prevalence of SPS and its association with morbidity and mortality in a well-characterized population-based cohort.
Methods: The study population consisted of 5,061 individuals from the Malmö Diet and Cancer cardiovascular cohort (MDC-CC) with baseline examinations between 1991 and 1994 and a median follow-up of 25.3 years (IQR = 5.7). The eGFRCYS/eGFRCR ratio was categorized into four groups and used to estimate a generalized propensity score for SPS to adjust for confounding factors. Individuals were matched to create a quartet (one from each eGFRCYS/eGFRCR ratio category) with similar scores. We related the eGFRCYS/eGFRCR ratio to all-cause mortality, incident cardiovascular disease, incident kidney disease, and incident diabetes using Cox proportional hazards models with shared frailty.
Results: SPS was detected in 405 individuals (8.0%). The hazard ratio (HR) for all-cause mortality was 1.6 [95% confidence interval (CI) 1.3-2.0] when comparing individuals with SPS to the reference group (eGFRCYS/eGFRCR ratio ≥ 1.0). For incident kidney disease, the association seems to stem from a low eGFRCYS rather than the eGFRCYS/eGFRCR ratio. For the other two outcomes, robust and statistically significant associations could not be found.
Conclusion: SPS was prevalent among middle-aged, generally healthy, individuals and led to markedly higher mortality during follow-up.
{"title":"Shrunken pore syndrome in relation to morbidity and mortality in the population-based Malmö Diet and Cancer cohort: a generalized propensity score approach.","authors":"Anna Åkesson, Liana Xhakollari, Agnė Laučytė-Cibulskiene, Anders Grubb, Anders Larsson, Amra Jujic, Martin Magnusson, Anders Christensson, Jonas Björk","doi":"10.3389/fepid.2025.1661167","DOIUrl":"10.3389/fepid.2025.1661167","url":null,"abstract":"<p><strong>Purpose: </strong>Glomerular filtration rate (GFR) is used for evaluating kidney function. Creatinine and cystatin C levels are the two endogenous substances used to estimate GFR (eGFR<sub>CR</sub> and eGFR<sub>CYS</sub>). The agreement between these two is reflected by the eGFR<sub>CYS</sub>/eGFR<sub>CR</sub> ratio. An eGFR<sub>CYS</sub>/eGFR<sub>CR</sub> ratio <0.70 has been strongly associated with mortality and morbidity. An explanation is a selective decrease in the filtration of substances of different masses, and this condition is referred to as \"Shrunken pore syndrome\" (SPS). We aim to investigate the prevalence of SPS and its association with morbidity and mortality in a well-characterized population-based cohort.</p><p><strong>Methods: </strong>The study population consisted of 5,061 individuals from the Malmö Diet and Cancer cardiovascular cohort (MDC-CC) with baseline examinations between 1991 and 1994 and a median follow-up of 25.3 years (IQR = 5.7). The eGFR<sub>CYS</sub>/eGFR<sub>CR</sub> ratio was categorized into four groups and used to estimate a generalized propensity score for SPS to adjust for confounding factors. Individuals were matched to create a quartet (one from each eGFR<sub>CYS</sub>/eGFR<sub>CR</sub> ratio category) with similar scores. We related the eGFR<sub>CYS</sub>/eGFR<sub>CR</sub> ratio to all-cause mortality, incident cardiovascular disease, incident kidney disease, and incident diabetes using Cox proportional hazards models with shared frailty.</p><p><strong>Results: </strong>SPS was detected in 405 individuals (8.0%). The hazard ratio (HR) for all-cause mortality was 1.6 [95% confidence interval (CI) 1.3-2.0] when comparing individuals with SPS to the reference group (eGFR<sub>CYS</sub>/eGFR<sub>CR</sub> ratio ≥ 1.0). For incident kidney disease, the association seems to stem from a low eGFR<sub>CYS</sub> rather than the eGFR<sub>CYS</sub>/eGFR<sub>CR</sub> ratio. For the other two outcomes, robust and statistically significant associations could not be found.</p><p><strong>Conclusion: </strong>SPS was prevalent among middle-aged, generally healthy, individuals and led to markedly higher mortality during follow-up.</p>","PeriodicalId":73083,"journal":{"name":"Frontiers in epidemiology","volume":"5 ","pages":"1661167"},"PeriodicalIF":0.0,"publicationDate":"2025-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12518306/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145304844","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-09-25eCollection Date: 2025-01-01DOI: 10.3389/fepid.2025.1595453
Yao Li
Introduction: This study aimed to investigate the excess mortality observed in China between 2020 and 2023 and its underlying causes, including the COVID-19 pandemic, sex ratio, and aging trends.
Methods: We collected data regarding number of deaths and mortality rates of the years 2015-2019 from the China Statistical Yearbook of Population and Employment, and analyzed the data by age and sex. We created a standardized sex and age structure dataset and compared the excess mortality rates of different sexes and age groups for the years 2020 to 2023.
Results: The sex-and age-specific number of deaths in all three years decreased compared to the number of deaths in the standardized sex and age structure dataset. The most significant decline was observed in 2021, whereas the number of deaths in 2022 and 2023 increased compared to that in 2021. It has been found that excess mortality is generally less prevalent among older age groups, and excess mortality rate tends to be lower among younger age groups. Additionally, in 2021, 2022, and 2023, the excess mortality rate was greater for men than for women, whereas it was greater for women in 2020. These differences can be attributed to various factors.
Discussion: This is the first study to examine excess mortality in China during the COVID-19 pandemic using age- and sex-standardized data. These findings underscore the need for a deeper exploration of the effects of sex and age on health outcomes.
{"title":"Sex- and age-specific differences in excess mortality in China during the COVID-19 pandemic: a study based on official vital statistics data.","authors":"Yao Li","doi":"10.3389/fepid.2025.1595453","DOIUrl":"10.3389/fepid.2025.1595453","url":null,"abstract":"<p><strong>Introduction: </strong>This study aimed to investigate the excess mortality observed in China between 2020 and 2023 and its underlying causes, including the COVID-19 pandemic, sex ratio, and aging trends.</p><p><strong>Methods: </strong>We collected data regarding number of deaths and mortality rates of the years 2015-2019 from the China Statistical Yearbook of Population and Employment, and analyzed the data by age and sex. We created a standardized sex and age structure dataset and compared the excess mortality rates of different sexes and age groups for the years 2020 to 2023.</p><p><strong>Results: </strong>The sex-and age-specific number of deaths in all three years decreased compared to the number of deaths in the standardized sex and age structure dataset. The most significant decline was observed in 2021, whereas the number of deaths in 2022 and 2023 increased compared to that in 2021. It has been found that excess mortality is generally less prevalent among older age groups, and excess mortality rate tends to be lower among younger age groups. Additionally, in 2021, 2022, and 2023, the excess mortality rate was greater for men than for women, whereas it was greater for women in 2020. These differences can be attributed to various factors.</p><p><strong>Discussion: </strong>This is the first study to examine excess mortality in China during the COVID-19 pandemic using age- and sex-standardized data. These findings underscore the need for a deeper exploration of the effects of sex and age on health outcomes.</p>","PeriodicalId":73083,"journal":{"name":"Frontiers in epidemiology","volume":"5 ","pages":"1595453"},"PeriodicalIF":0.0,"publicationDate":"2025-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12507777/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145281944","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-09-25eCollection Date: 2025-01-01DOI: 10.3389/fepid.2025.1636286
Kadio Jean Jacques Olivier Kadio, Thibaut Armel Chérif Gnimadi, Emilande Guichet, Castro Gbêmemali Hounmenou, Abdoul Karim Soumah, Haby Diallo, Amadou Camara, Saidouba Chérif Camara, Marie Rose Sandouno, Salifou Talassone Bangoura, Maladho Diaby, Vincent Richard, Julien Poublan, Sidikiba Sidibé, Alexandre Delamou, Alioune Camara, Alpha Kabinet Kéita, Eric Delaporte, Abdoulaye Touré
Background: In December 2019, the world experienced one of the significant health crises of the 21st century with the emergence and rapid spread of the potentially fatal 2019 coronavirus (COVID-19). In this context, sentinel surveillance of SARS-CoV-2 variants was conducted in Conakry. Here we report the first data on reproduction numbers and risk factors during the Omicron post-epidemic period in Guinea.
Methods: A sentinel syndromic and genomic surveillance study was conducted on suspected patients from October 2022 to July 2024 at healthcare facilities in Conakry. Individual data and nasopharyngeal swabs were collected and sent to the Centre de Recherche et de Formation en Infectiologie de Guinée (CERFIG) laboratory for screening and sequencing by next-generation sequencing (NGS). The effective reproduction number (Rt) were estimated using EpiEstim to assess the transmission potential of the Omicron variant. Generalized linear models based on the binomial distribution were employed to analyze factors associated with SARS-CoV-2 positivity, following the identification of primary risk factors using Bayesian model averaging and the Data balancing algorithm using propensity score matching.
Results: Data from 1174 patients with suspected cases with a median age of 31 years (IQR: 20-51), were analyzed. The overall COVID-19 positivity rate was 11.8%. The global effective reproduction number (Rt) was 2.08 [95% CI: 0.35-5.81]. Only ageusia [AOR = 2.0; 95% CI (1.1-3.6)] was independently associated with SARS-CoV-2 test positivity.
Conclusion: SARS-CoV-2 is still circulating in Guinea, with a high positivity rate and a high number of effective reproductions in this post-epidemic period in our country. The associated factors and the circulation of variants with a diversity of circulating strains suggest the need to strengthen genomic and epidemiological surveillance, with the support of all those involved in the response to COVID-19, to ensure continuity of alerts and decision-making for public health.
{"title":"Assessing the long-term persistence of SARS-CoV-2 in Guinea: insights from post-epidemic sentinel syndromic surveillance data.","authors":"Kadio Jean Jacques Olivier Kadio, Thibaut Armel Chérif Gnimadi, Emilande Guichet, Castro Gbêmemali Hounmenou, Abdoul Karim Soumah, Haby Diallo, Amadou Camara, Saidouba Chérif Camara, Marie Rose Sandouno, Salifou Talassone Bangoura, Maladho Diaby, Vincent Richard, Julien Poublan, Sidikiba Sidibé, Alexandre Delamou, Alioune Camara, Alpha Kabinet Kéita, Eric Delaporte, Abdoulaye Touré","doi":"10.3389/fepid.2025.1636286","DOIUrl":"10.3389/fepid.2025.1636286","url":null,"abstract":"<p><strong>Background: </strong>In December 2019, the world experienced one of the significant health crises of the 21st century with the emergence and rapid spread of the potentially fatal 2019 coronavirus (COVID-19). In this context, sentinel surveillance of SARS-CoV-2 variants was conducted in Conakry. Here we report the first data on reproduction numbers and risk factors during the Omicron post-epidemic period in Guinea.</p><p><strong>Methods: </strong>A sentinel syndromic and genomic surveillance study was conducted on suspected patients from October 2022 to July 2024 at healthcare facilities in Conakry. Individual data and nasopharyngeal swabs were collected and sent to the Centre de Recherche et de Formation en Infectiologie de Guinée (CERFIG) laboratory for screening and sequencing by next-generation sequencing (NGS). The effective reproduction number (Rt) were estimated using EpiEstim to assess the transmission potential of the Omicron variant. Generalized linear models based on the binomial distribution were employed to analyze factors associated with SARS-CoV-2 positivity, following the identification of primary risk factors using Bayesian model averaging and the Data balancing algorithm using propensity score matching.</p><p><strong>Results: </strong>Data from 1174 patients with suspected cases with a median age of 31 years (IQR: 20-51), were analyzed. The overall COVID-19 positivity rate was 11.8%. The global effective reproduction number (Rt) was 2.08 [95% CI: 0.35-5.81]. Only ageusia [AOR = 2.0; 95% CI (1.1-3.6)] was independently associated with SARS-CoV-2 test positivity.</p><p><strong>Conclusion: </strong>SARS-CoV-2 is still circulating in Guinea, with a high positivity rate and a high number of effective reproductions in this post-epidemic period in our country. The associated factors and the circulation of variants with a diversity of circulating strains suggest the need to strengthen genomic and epidemiological surveillance, with the support of all those involved in the response to COVID-19, to ensure continuity of alerts and decision-making for public health.</p>","PeriodicalId":73083,"journal":{"name":"Frontiers in epidemiology","volume":"5 ","pages":"1636286"},"PeriodicalIF":0.0,"publicationDate":"2025-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12507806/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145281979","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-09-17eCollection Date: 2025-01-01DOI: 10.3389/fepid.2025.1547867
Isaac Fwemba, Samuel Iddi, Thabane Lehane, Alfred Yawson, Jacques L Tamuzi, Peter S Nyasulu, Samuel Bosomprah
Background: Implementation research (IR) studies and clinical trials have yielded conflicting results on improving treatment outcomes, especially among adolescent patients. To address this, we performed a Bayesian random-effects meta-analysis to evaluate the effectiveness of current IR interventions in improving retention in care and reducing viral suppression among HIV-infected adolescents.
Method: A comprehensive search was conducted from 1 January 2000 to 31 December 2020. A Bayesian random-effects meta-analysis was performed using historical evidence from adolescent interventions conducted outside sub-Saharan Africa (SSA) and from adult-derived interventions within SSA. A Bayesian Copas random-effects model was used to account for publication bias and study variations. Power priors were used to weight the contribution of historical data to the analysis. Bayesian meta-analysis was particularly suited for this study since it allowed us to directly include prior assessments from several intervention studies into the pooled intervention data.
Results: The pooled results from the 12 studies across eight African countries, involving 19,223 adolescent patients, showed significantly superior retention effects in adolescent-specialized interventions compared to standard care settings [odds ratio (OR) = 3.87; 95% credible interval (CrI): 0.94-10.82]. When 100% of data from eight observational studies on adolescent treatment outcomes were added to the analysis, the resulting OR was 3.02 (95% CrI: 1.01, 6.92). However, inclusion of 100% of historical data from adult randomised control trials (RCTs) reduced the retention effect to OR = 1.24 (95% CrI: 1.03-1.48). Regardless of whether adolescent historical data or adult RCT data were used, the associated posterior probability of benefiting from the intervention remained almost 1. There was no difference between standard care and specialized adolescent care in terms of virological suppression (OR = 1.27; 95% CrI: 0.57-2.32). However, specialized adolescent intervention achieved a superior overall retention rate of 59.7% compared to 52.1% under standard care.
Conclusion: Current adolescent-specific interventions are effective in improving retention rates in HIV care. Evidence from adult interventions showed a reduced retention effect, suggesting that while adult-promising interventions may improve adolescent treatment outcomes, they may require modifications.
{"title":"Bayesian meta-analysis of the effectiveness of implementation science evidence in improving health outcomes for adolescent patients accessing ART in sub-Saharan Africa.","authors":"Isaac Fwemba, Samuel Iddi, Thabane Lehane, Alfred Yawson, Jacques L Tamuzi, Peter S Nyasulu, Samuel Bosomprah","doi":"10.3389/fepid.2025.1547867","DOIUrl":"10.3389/fepid.2025.1547867","url":null,"abstract":"<p><strong>Background: </strong>Implementation research (IR) studies and clinical trials have yielded conflicting results on improving treatment outcomes, especially among adolescent patients. To address this, we performed a Bayesian random-effects meta-analysis to evaluate the effectiveness of current IR interventions in improving retention in care and reducing viral suppression among HIV-infected adolescents.</p><p><strong>Method: </strong>A comprehensive search was conducted from 1 January 2000 to 31 December 2020. A Bayesian random-effects meta-analysis was performed using historical evidence from adolescent interventions conducted outside sub-Saharan Africa (SSA) and from adult-derived interventions within SSA. A Bayesian Copas random-effects model was used to account for publication bias and study variations. Power priors were used to weight the contribution of historical data to the analysis. Bayesian meta-analysis was particularly suited for this study since it allowed us to directly include prior assessments from several intervention studies into the pooled intervention data.</p><p><strong>Results: </strong>The pooled results from the 12 studies across eight African countries, involving 19,223 adolescent patients, showed significantly superior retention effects in adolescent-specialized interventions compared to standard care settings [odds ratio (OR) = 3.87; 95% credible interval (CrI): 0.94-10.82]. When 100% of data from eight observational studies on adolescent treatment outcomes were added to the analysis, the resulting OR was 3.02 (95% CrI: 1.01, 6.92). However, inclusion of 100% of historical data from adult randomised control trials (RCTs) reduced the retention effect to OR = 1.24 (95% CrI: 1.03-1.48). Regardless of whether adolescent historical data or adult RCT data were used, the associated posterior probability of benefiting from the intervention remained almost 1. There was no difference between standard care and specialized adolescent care in terms of virological suppression (OR = 1.27; 95% CrI: 0.57-2.32). However, specialized adolescent intervention achieved a superior overall retention rate of 59.7% compared to 52.1% under standard care.</p><p><strong>Conclusion: </strong>Current adolescent-specific interventions are effective in improving retention rates in HIV care. Evidence from adult interventions showed a reduced retention effect, suggesting that while adult-promising interventions may improve adolescent treatment outcomes, they may require modifications.</p>","PeriodicalId":73083,"journal":{"name":"Frontiers in epidemiology","volume":"5 ","pages":"1547867"},"PeriodicalIF":0.0,"publicationDate":"2025-09-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12484029/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145214646","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-09-12eCollection Date: 2025-01-01DOI: 10.3389/fepid.2025.1643323
Ricardo Yajamín-Villamarín
Background: Gastric cancer (GC) is a major public health issue and a leading cause of cancer-related mortality in Ecuador. Despite national cancer control efforts, the burden remains high, with variations by gender and age. This study aimed to quantify the burden of GC in Ecuador from 2010 to 2021 using Disability-Adjusted Life Years (DALYs), providing insights for public health strategies.
Methods: A cross-sectional study was conducted using hospital discharge and mortality data from the National Institute of Statistics and Census (INEC). The study included all Ecuadorian individuals diagnosed with GC (ICD-10: C16) from 2010 to 2021. The burden of disease was estimated using DALYs, which combined Years of Life Lost (YLL) and Years Lived with Disability (YLD). Data were stratified by gender and age groups. Analyses were performed using Microsoft Excel and the DALY calculator in R v4.2.1.
Results: Between 2010 and 2021, GC accounted for 802,135 DALYs in Ecuador, with an annual average of 66,845 DALYs. Males accounted for 57.2% of the total burden. The highest impact was observed in individuals aged 65-69 years. A progressive increase in disease burden was identified, particularly among older age groups.
Conclusions: The findings highlight the need for targeted interventions, including early detection programs, risk reduction strategies, and improved healthcare access. Strengthening public health policies is crucial to mitigating the rising burden of GC in Ecuador.
{"title":"Burden of gastric cancer in Ecuador (2010-2021): a gender- and age-specific analysis using disability-adjusted life years (DALYs).","authors":"Ricardo Yajamín-Villamarín","doi":"10.3389/fepid.2025.1643323","DOIUrl":"10.3389/fepid.2025.1643323","url":null,"abstract":"<p><strong>Background: </strong>Gastric cancer (GC) is a major public health issue and a leading cause of cancer-related mortality in Ecuador. Despite national cancer control efforts, the burden remains high, with variations by gender and age. This study aimed to quantify the burden of GC in Ecuador from 2010 to 2021 using Disability-Adjusted Life Years (DALYs), providing insights for public health strategies.</p><p><strong>Methods: </strong>A cross-sectional study was conducted using hospital discharge and mortality data from the National Institute of Statistics and Census (INEC). The study included all Ecuadorian individuals diagnosed with GC (ICD-10: C16) from 2010 to 2021. The burden of disease was estimated using DALYs, which combined Years of Life Lost (YLL) and Years Lived with Disability (YLD). Data were stratified by gender and age groups. Analyses were performed using Microsoft Excel and the DALY calculator in R v4.2.1.</p><p><strong>Results: </strong>Between 2010 and 2021, GC accounted for 802,135 DALYs in Ecuador, with an annual average of 66,845 DALYs. Males accounted for 57.2% of the total burden. The highest impact was observed in individuals aged 65-69 years. A progressive increase in disease burden was identified, particularly among older age groups.</p><p><strong>Conclusions: </strong>The findings highlight the need for targeted interventions, including early detection programs, risk reduction strategies, and improved healthcare access. Strengthening public health policies is crucial to mitigating the rising burden of GC in Ecuador.</p>","PeriodicalId":73083,"journal":{"name":"Frontiers in epidemiology","volume":"5 ","pages":"1643323"},"PeriodicalIF":0.0,"publicationDate":"2025-09-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12463957/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145187550","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-09-11eCollection Date: 2025-01-01DOI: 10.3389/fepid.2025.1571065
Mohamed Ali Daw, Abdallah H El-Bouzedi, Saleh Ali Abumahara, Abdurrahman Khalifa Najjar, Nouri R Ben Ashur, Alaa Grebi, Amnnh Mohammed Dhu, Ali Fathi Alkarghali, Shahid Husayn Mohammed, Raja Khalid Miftah, Najmuldin Abdulbasit Abdulsamad, Mohammed Saad Elbasha, Asawer Seifennaser Doukali, Nosieba Taher Elmhidwi, Esra Othman Albouzaidi, Said Emhamed Wareg, Mohamed Omar Ahmed
Introduction: Tuberculosis(TB) is still a serious problem with a remarkable global impacts particularly within developing countries such as Libya. According to World Health Organization (WHO) global report, the country is considered a moderate TB burden with incidence of 40 per 100,000 in 2011. Geographic epidemiology has been considered an important tool in preventing TB in large countries. In this study, we intended to identify the geographic and spatiotemporal patterns of the TB incidence rate in Libya between 2015 and 2024.
Methods: A cross-sectional retrospective analytical study was conducted within ten years on the data reported through the National TB surveillance system. The data on all TB cases reported from 2015 to 2024 by municipality and region was abstracted. Choropleth maps were drawn showing the TB case notification rates (CNR) per 100,000. Local Moran's I was performed to identify the spatial variations of the disease and temporal and Spatiotemporal analyses were employed in all instances.
Results: During the entire study period, 26,478 TB cases were reported from all 22 municipalities in Libya with an annual rate of 40.29/100,000 (95% CI: (40.229 ± 9.01). The highest incidence was reported in 2015 and the lowest one in 2024. Males were significantly reported more than females among notified TB cases, (P < 0.001). The highest CNR was reported in the Eastern region followed by Western and Southern regions. The geospatial distribution of reported cases of TB varied greatly within the provinces and during the study period. There was evident variability throughout the country and over time. High-rate and low-rate clusters were predominantly distributed in the periods. High clusters were concentrated northeast and northwest, though low-level clusters were mainly located in the middle and the southern region of the country.
Conclusion: The results of this study provided clear insights into the geographic and spatiotemporal mapping of TB in Libya. There was an overall decreasing trend in TB CNR from 2015 to 2024 parallel with high-risk and low-risk areas. This information should allow the decision-making personnel to implement proper policies to combat TB at national and regional levels.
{"title":"Geographic mapping and spatiotemporal patterns of tuberculosis in Libya within ten years' period (2015 to 2024).","authors":"Mohamed Ali Daw, Abdallah H El-Bouzedi, Saleh Ali Abumahara, Abdurrahman Khalifa Najjar, Nouri R Ben Ashur, Alaa Grebi, Amnnh Mohammed Dhu, Ali Fathi Alkarghali, Shahid Husayn Mohammed, Raja Khalid Miftah, Najmuldin Abdulbasit Abdulsamad, Mohammed Saad Elbasha, Asawer Seifennaser Doukali, Nosieba Taher Elmhidwi, Esra Othman Albouzaidi, Said Emhamed Wareg, Mohamed Omar Ahmed","doi":"10.3389/fepid.2025.1571065","DOIUrl":"10.3389/fepid.2025.1571065","url":null,"abstract":"<p><strong>Introduction: </strong>Tuberculosis(TB) is still a serious problem with a remarkable global impacts particularly within developing countries such as Libya. According to World Health Organization (WHO) global report, the country is considered a moderate TB burden with incidence of 40 per 100,000 in 2011. Geographic epidemiology has been considered an important tool in preventing TB in large countries. In this study, we intended to identify the geographic and spatiotemporal patterns of the TB incidence rate in Libya between 2015 and 2024.</p><p><strong>Methods: </strong>A cross-sectional retrospective analytical study was conducted within ten years on the data reported through the National TB surveillance system. The data on all TB cases reported from 2015 to 2024 by municipality and region was abstracted. Choropleth maps were drawn showing the TB case notification rates (CNR) per 100,000. Local Moran's I was performed to identify the spatial variations of the disease and temporal and Spatiotemporal analyses were employed in all instances.</p><p><strong>Results: </strong>During the entire study period, 26,478 TB cases were reported from all 22 municipalities in Libya with an annual rate of 40.29/100,000 (95% CI: (40.229 ± 9.01). The highest incidence was reported in 2015 and the lowest one in 2024. Males were significantly reported more than females among notified TB cases, (<i>P</i> < 0.001). The highest CNR was reported in the Eastern region followed by Western and Southern regions. The geospatial distribution of reported cases of TB varied greatly within the provinces and during the study period. There was evident variability throughout the country and over time. High-rate and low-rate clusters were predominantly distributed in the periods. High clusters were concentrated northeast and northwest, though low-level clusters were mainly located in the middle and the southern region of the country.</p><p><strong>Conclusion: </strong>The results of this study provided clear insights into the geographic and spatiotemporal mapping of TB in Libya. There was an overall decreasing trend in TB CNR from 2015 to 2024 parallel with high-risk and low-risk areas. This information should allow the decision-making personnel to implement proper policies to combat TB at national and regional levels.</p>","PeriodicalId":73083,"journal":{"name":"Frontiers in epidemiology","volume":"5 ","pages":"1571065"},"PeriodicalIF":0.0,"publicationDate":"2025-09-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12460455/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145187581","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-09-11eCollection Date: 2025-01-01DOI: 10.3389/fepid.2025.1663372
Angela K Moturi, Moses M Musau, Samuel K Muchiri, Peter M Macharia, Robert W Snow, Emelda A Okiro
Background: Missed opportunities for key vaccinations continue to exacerbate disease outbreaks. Accurately monitoring immunisation coverage is fundamental to identifying gaps in vaccine delivery and informing timely action. This study assesses the agreement between routine and survey-based coverage estimates for the second dose of the measles vaccine (MCV2) in Western Kenya.
Methods: This study utilised model-based geostatistics estimates MCV2 coverage from the 2022 Kenya Demographic and Health Survey (DHS), monthly immunisation data from routine health information systems (2019-2022) imputed for missingness and population data from WorldPop for 2019 across 62 Western Kenyan subnational areas (sub-counties). Routine MCV2 coverage was computed using MCV2 doses as a numerator and two separate denominators: (i) Pentavalent 1 doses to account for children already receiving prior vaccines at health facilities (service-based coverage) and (ii) surviving infants to account for all eligible children (population-based coverage). Concordance was assessed using the 95% confidence intervals (CIs) of survey-modelled estimates, intra-class correlation coefficient (ICC), and Bland-Altman (BA) plots.
Results: Survey-modelled estimates differed substantially in 55 (89%) and 39 (63%) sub-counties compared to population and service-based coverage estimates respectively. The different approaches showed poor congruence in survey-modelled vs. population-based coverage estimates (ICC: 0.10, p = 0.229) and survey-modelled vs. service-based coverage estimates (ICC: 0.42, p = <0.001); there was moderate congruence of population vs. service-based coverage estimates (ICC: 0.65, p = <0.001). Survey-modelled vs. population-based coverage estimates showed the highest bias in BA plots of 18.80 percent points (p.p) compared to 11.02 p.p. and 7.79 p.p. between survey-modelled vs. service-based coverage and population vs. service-based coverage estimates, respectively.
Conclusions: Substantial discrepancies among survey-modelled, routine population, and service-based coverage estimates expose important variations in each approaches' results. While all approaches offer distinct insights, improving survey models, routine data quality and refining estimates of population catchment is imperative for reliable fine-scale vaccine delivery monitoring.
背景:错过关键疫苗接种机会继续加剧疾病暴发。准确监测免疫覆盖率对于确定疫苗提供方面的差距和及时通报行动至关重要。本研究评估了肯尼亚西部常规和基于调查的第二剂麻疹疫苗(MCV2)覆盖率估计之间的一致性。方法:本研究利用基于模型的地质统计学估计2022年肯尼亚人口与健康调查(DHS)的MCV2覆盖率,来自常规卫生信息系统(2019-2022年)的月度免疫接种数据,以及来自世界人口普查的2019年肯尼亚西部62个次国家地区(次县)的人口数据。常规MCV2接种覆盖率是使用MCV2剂量作为分子和两个单独的分母来计算的:(i)五价1剂量,用于计算已经在卫生设施接种过疫苗的儿童(以服务为基础的覆盖率);(ii)存活婴儿,用于计算所有符合条件的儿童(以人口为基础的覆盖率)。使用调查模型估计的95%置信区间(ci)、类内相关系数(ICC)和Bland-Altman (BA)图评估一致性。结果:在55个(89%)和39个(63%)副县中,调查模型估计与基于人口和基于服务的覆盖率估计相比存在很大差异。不同的方法在基于调查模型的覆盖率估计与基于人口的覆盖率估计(ICC: 0.10, p = 0.229)和基于调查模型的覆盖率估计与基于服务的覆盖率估计(ICC: 0.42, p = p =结论:基于调查模型的、常规人口的和基于服务的覆盖率估计之间的巨大差异暴露了每种方法结果的重要差异。虽然所有方法都提供不同的见解,但改进调查模型、常规数据质量和改进人口集水区估计对于可靠的小规模疫苗交付监测至关重要。
{"title":"Concordance of coverage estimates from routine and survey data of measles second dose vaccine in Western Kenya.","authors":"Angela K Moturi, Moses M Musau, Samuel K Muchiri, Peter M Macharia, Robert W Snow, Emelda A Okiro","doi":"10.3389/fepid.2025.1663372","DOIUrl":"10.3389/fepid.2025.1663372","url":null,"abstract":"<p><strong>Background: </strong>Missed opportunities for key vaccinations continue to exacerbate disease outbreaks. Accurately monitoring immunisation coverage is fundamental to identifying gaps in vaccine delivery and informing timely action. This study assesses the agreement between routine and survey-based coverage estimates for the second dose of the measles vaccine (MCV2) in Western Kenya.</p><p><strong>Methods: </strong>This study utilised model-based geostatistics estimates MCV2 coverage from the 2022 Kenya Demographic and Health Survey (DHS), monthly immunisation data from routine health information systems (2019-2022) imputed for missingness and population data from WorldPop for 2019 across 62 Western Kenyan subnational areas (sub-counties). Routine MCV2 coverage was computed using MCV2 doses as a numerator and two separate denominators: (i) Pentavalent 1 doses to account for children already receiving prior vaccines at health facilities (service-based coverage) and (ii) surviving infants to account for all eligible children (population-based coverage). Concordance was assessed using the 95% confidence intervals (CIs) of survey-modelled estimates, intra-class correlation coefficient (ICC), and Bland-Altman (BA) plots.</p><p><strong>Results: </strong>Survey-modelled estimates differed substantially in 55 (89%) and 39 (63%) sub-counties compared to population and service-based coverage estimates respectively. The different approaches showed poor congruence in survey-modelled vs. population-based coverage estimates (ICC: 0.10, <i>p</i> = 0.229) and survey-modelled vs. service-based coverage estimates (ICC: 0.42, <i>p</i> = <0.001); there was moderate congruence of population vs. service-based coverage estimates (ICC: 0.65, <i>p</i> = <0.001). Survey-modelled vs. population-based coverage estimates showed the highest bias in BA plots of 18.80 percent points (p.p) compared to 11.02 p.p. and 7.79 p.p. between survey-modelled vs. service-based coverage and population vs. service-based coverage estimates, respectively.</p><p><strong>Conclusions: </strong>Substantial discrepancies among survey-modelled, routine population, and service-based coverage estimates expose important variations in each approaches' results. While all approaches offer distinct insights, improving survey models, routine data quality and refining estimates of population catchment is imperative for reliable fine-scale vaccine delivery monitoring.</p>","PeriodicalId":73083,"journal":{"name":"Frontiers in epidemiology","volume":"5 ","pages":"1663372"},"PeriodicalIF":0.0,"publicationDate":"2025-09-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12460269/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145187567","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-07-29eCollection Date: 2025-01-01DOI: 10.3389/fepid.2025.1605058
Allyson Murray, Anna Ignaszak
The recent analysis by Mora and colleagues revealed that over 277 diseases can worsen due to climatic hazards resulting from greenhouse gas emissions. Specifically, more than 58% of known human diseases can be aggravated by climate change. Furthermore, there are over 1,000 pathways through which various climatic hazards have contributed to disease outbreaks, primarily due to the diversity of pathogens. This analysis also urges immediate action to address the root of the problem-reducing greenhouse gas (GHG) emissions. Numerous climatic hazards affect the incidence of human pathogenic diseases. Unfortunately, due to the complexity and multifaceted nature of the problem, there cannot be a single comprehensive solution to minimize climate-driven outbreaks. This study seeks to identify outbreaks of specific diseases categorized as epidemics, whose incidence is strongly correlated with global warming. The focus of this analysis is on (1) organizations responding to climate-related diseases to decelerate the incidence rates; (2) to call for a new disciplines in epidemiology that focuses exclusively on climate change-related prediction for future pandemics; (3) looking at the problem from the patient's point of view-how do non-medical/health professionals contribute to minimizing the spread of climate-related diseases?; (4) to analyze outbreaks vs. urbanization/pollution/increase in population density and public health policies; also (5) to verify the vaccination coverage vs. case reduction rate.
{"title":"Mapping climate change-driven epidemics.","authors":"Allyson Murray, Anna Ignaszak","doi":"10.3389/fepid.2025.1605058","DOIUrl":"10.3389/fepid.2025.1605058","url":null,"abstract":"<p><p>The recent analysis by Mora and colleagues revealed that over 277 diseases can worsen due to climatic hazards resulting from greenhouse gas emissions. Specifically, more than 58% of known human diseases can be aggravated by climate change. Furthermore, there are over 1,000 pathways through which various climatic hazards have contributed to disease outbreaks, primarily due to the diversity of pathogens. This analysis also urges immediate action to address the root of the problem-reducing greenhouse gas (GHG) emissions. Numerous climatic hazards affect the incidence of human pathogenic diseases. Unfortunately, due to the complexity and multifaceted nature of the problem, there cannot be a single comprehensive solution to minimize climate-driven outbreaks. This study seeks to identify outbreaks of specific diseases categorized as epidemics, whose incidence is strongly correlated with global warming. The focus of this analysis is on (1) organizations responding to climate-related diseases to decelerate the incidence rates; (2) to call for a new disciplines in epidemiology that focuses exclusively on climate change-related prediction for future pandemics; (3) looking at the problem from the patient's point of view-how do non-medical/health professionals contribute to minimizing the spread of climate-related diseases?; (4) to analyze outbreaks vs. urbanization/pollution/increase in population density and public health policies; also (5) to verify the vaccination coverage vs. case reduction rate.</p>","PeriodicalId":73083,"journal":{"name":"Frontiers in epidemiology","volume":"5 ","pages":"1605058"},"PeriodicalIF":0.0,"publicationDate":"2025-07-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12339543/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144838747","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}